Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|November 17, 2009
Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin studyGreta Snellman, Håkan Melhus, Rolf Gedeborg, et al.
European Heart Journal|November 6, 2007
Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarctionTibor Kempf, Erik Björklund, Sylvia Olofsson, et al.
Circulation|September 13, 2007
Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndromeKai C Wollert, Tibor Kempf, Bo Lagerqvist, et al.
American Heart Journal|March 3, 2009
Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirinChristoph Varenhorst, Stefan James, David Erlinge, et al.
European Heart Journal|June 30, 2009
Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) StudyLars Lind, Lars Wallentin, Tibor Kempf, et al.
Circulation. Cardiovascular Genetics|February 18, 2010
Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndromeKai M Eggers, Tibor Kempf, Bo Lagerqvist, et al.
Circulation|February 7, 2007
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndromeKai C Wollert, Tibor Kempf, Timo Peter, et al.
Circulation|November 10, 2010
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysisPhilippe Gabriel Steg, Stefan James, Robert A Harrington, et al.
Pageof 1